A STABLE NICHE IN BIG PHARMA
Many investors would love to experience the explosive upside that biotech and
pharmaceutical companies can offer when major blockbuster drugs get approved,
but don't have the stomach for the risk that the drug might crash and burn,
dragging the company's stock down with it. You're probably familiar with stories
of entrepreneurs such as Levi Strauss, who struck it rich in the California
gold rush not by hitting gold, but by selling picks, shovels, and his eponymous
jeans to prospectors.